Drug Shortage Report for JAMP-OLOPATADINE

Last updated on 2021-08-31 History
Report ID 96218
Drug Identification Number 02458411
Brand name JAMP-OLOPATADINE
Common or Proper name Olopatadine
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) OLOPATADINE
Strength(s) 0.1%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5
ATC code S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-07
Estimated end date
Actual end date 2021-06-11
Shortage status Resolved
Updated date 2021-08-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2021-08-31 French Compare
v15 2021-08-31 English Compare
v14 2021-04-07 French Compare
v13 2021-04-07 English Compare
v12 2020-09-04 French Compare
v11 2020-09-04 English Compare
v10 2020-06-19 French Compare
v9 2020-06-19 English Compare
v8 2020-04-29 French Compare
v7 2020-04-29 English Compare
v6 2020-02-18 French Compare
v5 2020-02-18 English Compare
v4 2019-12-10 French Compare
v3 2019-12-10 English Compare
v2 2019-10-11 French Compare
v1 2019-10-11 English Compare

Showing 1 to 16 of 16